US Breast Pump Market Report

US Breast Pump Market Executive Summary

The US Breast Pump Market is at around $1234.8 Mn in 2023 and is projected to reach $1931.5 Mn in 2030, exhibiting a CAGR of 6.6% during the forecast period.

A breast pump is a mechanical device that lactating women use to extract milk from their breasts. They are available in two forms; they can be manual devices powered by hand or foot movements or automatic devices powered by electricity. Breast pumps are available in a variety of styles to meet the demands of moms. Hand-operated manual pumps are lightweight and silent, making them ideal for sporadic usage. Electric pumps are often used on a regular basis because of their higher efficiency and ability to run on mains or batteries. There are several uses for breast pumps. Many parents use them to continue breastfeeding after they return to work. They express their milk at work, which is later bottle-fed to their child by a caregiver. A breast pump may also be used to address a range of challenges parents may encounter during breastfeeding, including difficulties latching, separation from an infant in intensive care, feeding an infant who cannot extract sufficient milk itself from the breast, to avoid passing medication through breast milk to the baby, or to relieve engorgement, which is a painful condition whereby the breasts are overfull.

The US Breast Pump Market is driven by significant factors such as the rising female workforce, product innovations, and growing consumer awareness. However, stringent regulations, physical discomfort, stigma, and embarrassment restrict the growth and potential of the market.

The major players in the US Breast Pump Market are Magento Dr. Brown’s, Freemie, Evenflo, Nuk, Hygeia, Spectra Baby, Willow, Momcozy, and iAPOY, among others. Ameda, a part of Magento, Inc., is a leading manufacturer of breast pumps known for their innovative designs and efficient performance. Their pumps are designed to mimic natural breastfeeding patterns for optimal milk expression.

Market Dynamics

Market Growth Drivers

Rising Female Workforce: In 2023, women comprised 47% of the U.S. civilian labor force, a significant increase from 30% in 1950. As more women balance careers with motherhood, the demand for convenient breastfeeding solutions that fit their professional lives is growing. Breast pumps are becoming essential for working mothers, enabling them to continue breastfeeding while meeting work commitments. This rising need for breastfeeding-friendly solutions is driving the market for breast pumps and related products.

Product Innovations: Advances in breast pumps such as wearable, hands-free models, improved suction technologies, and smart features like app connectivity have significantly enhanced user convenience and comfort. These continuous improvements not only address the evolving needs of breastfeeding mothers but also stimulate market growth by attracting consumers seeking the latest and most efficient solutions for breastfeeding.

Growing consumer awareness: As information about the advantages of breastfeeding and the convenience of breast pumps becomes more widely available through healthcare professionals, online resources, and social media, more mothers are opting for these devices. Support from health organizations and government initiatives advocating for breastfeeding also contributes to this heightened awareness. Furthermore, the demand for adaptable parenting solutions and workplace accommodations for breastfeeding mothers has led to higher adoption of breast pumps, further fuelling market growth.

Market Restraints

Stringent Regulations: The US (Food and Drugs Administration) FDA enforces strict standards to guarantee the safety, effectiveness, and quality of breast pumps. These regulations demand comprehensive testing, certification, and documentation, which can be both expensive and time-consuming for manufacturers. Additionally, dealing with varying regulatory requirements across international markets adds further complexity. This increased regulatory burden can delay product introductions, restrict market access for smaller companies, and potentially raise prices for consumers, which can slow down market growth.

Physical Discomfort: The use of breast pumps often results in physical discomfort, such as sore and cracked nipples, pain from incorrect flange sizes or excessive suction, and hand fatigue from manual pumps. These issues can greatly affect a mother's pumping experience, making it crucial to choose the right pump, ensure proper fit, and use pain management techniques. These physical challenges contribute to an overall reduction in market growth.

Stigma and Embarrassment: Negative social attitudes and stigma related to breast pump usage can impede the growth of the breast pump market. Cultural and social biases against breastfeeding and breast pump use may deter some women from using these devices, particularly in public or professional settings. Concerns about the visibility of the pump, fear of judgment, and inadequate support from employers and society further contribute to this reluctance. These societal obstacles can hinder the broader acceptance and adoption of breast pumps, potentially restricting market expansion.

Regulatory Landscape and Reimbursement Scenario

The United States Food and Drug Administration (USFDA) is a federal agency of the Department of Health and Human Services. The main goal of the USFDA is to protect public health by ensuring the safety and efficacy of drugs, biological products, and medical equipment, along with food, cosmetics, and items that emit radiation. The Federal Food, Drug, and Cosmetic Act and several other comparable statutes are enforced by the FDA.

The process of gaining approval of new drugs involves rigorous and cumbersome evaluation by the USFDA. The two divisions of the USFDA, the Centre for Drug Evaluation and Research (CDER) and the Centre for Biologics Evaluation and Research (CBER) extensively review applications for approval which makes it challenging for pharmaceutical companies to bring a new product to the market. The various types of applications submitted to the USFDA for getting approval for pharmaceuticals include Investigational New Drug Application (INDA), New Drug Application (NDA), Abbreviated New Drug Application (ANDA) for generic drugs, and Biologics License Application (BLA).

Medicare and Medicaid are two of the health insurance programs administered by the US Government, with differences in covered services and cost-sharing. Medicare is a government health insurance program available to Americans 65 years of age or older, as well as to younger individuals with disabilities. Medicaid provides health coverage to low-income families, based on eligibility determined by comparing the income with the federal poverty level. Initially launched in 1965 by the Social Security Administration, the Centres for Medicare and Medicaid Services (CMS) currently oversee its administration. Medicare and Medicaid thus provide financial security lessen the financial burden of healthcare and provide better outcomes for beneficiaries.

Competitive Landscape

Key Players

Here are some of the major key players in the US Breast Pump Market:

• Magento (Ameda)
• Dr. Brown’s
• Freemie
• Evenflo
• Nuk
• Hygeia
• Spectra Baby
• Willow
• Momcozy
• iAPOY